Policy Working Group
The EATG has lobbied at the European level since 1998 in the interests of people living with HIV and AIDS for better, more equal and quicker access to vital medication.
These activities have involved monitoring the political health agenda of the EU Institutions (European Commission and Parliament) as well as the European Medicinal Evaluation Agency (EMEA) and its Committee for Human Medicinal Products (CHMP) on specific issues which it believes have an impact on the EATG and the European HIV/AIDS community.
Objectives
- To closely monitor the EU agenda on issues that affect the goals of the EATG and report on developments to the EATG and its board of directors.
- To prioritise those political initiatives and issues likely to have the greatest impact upon the aims of the EATG, set up action plans and undertake active advocacy work on them.
- To promote the EATG, its role and its policies to the European and multilateral institutions and their decision makers.
- To represent the EATG and its mission statement versus public health institutions and European and international policy makers.
- To lobby and advocate for equal and wide access to HIV treatment and care, access to care and for the respect of human and health rights of people affected or threatened by HIV and AIDS.
- To develop and publish EATG position papers on the public health and HIV-related policies.
- To lobby for better organisation and legislation of clinical trials throughout Europe.
- To produce information materials laying out EATG policy positions and to support its policy activities.
- To work together with other NGOs and key opinion leaders within the European environment to further EATG goals as and when appropriate.
Chairs:
Share this page
More...
